Drug Shortage Report for SANDOZ IRBESARTAN
Report ID | 74642 |
Drug Identification Number | 02328488 |
Brand name | SANDOZ IRBESARTAN |
Common or Proper name | IRBESARTAN |
Company Name | SANDOZ CANADA INCORPORATED |
Market Status | MARKETED |
Active Ingredient(s) | IRBESARTAN |
Strength(s) | 150MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 500 |
ATC code | C09CA |
ATC description | ANGIOTENSIN II ANTAGONISTS, PLAIN |
Reason for shortage | Requirements related to complying with good manufacturing practices. |
Anticipated start date | |
Actual start date | 2018-11-01 |
Estimated end date | 2020-10-23 |
Actual end date | 2020-10-23 |
Shortage status | Resolved |
Updated date | 2020-10-27 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 110 RUE DE LAUZON BOUCHERVILLE, QUEBEC CANADA J4B 1E6 |
Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v56 | 2020-10-27 | French | Compare |
v55 | 2020-10-27 | English | Compare |
v54 | 2020-10-27 | French | Compare |
v53 | 2020-10-27 | English | Compare |
v52 | 2020-10-13 | French | Compare |
v51 | 2020-10-13 | English | Compare |
v50 | 2020-10-05 | French | Compare |
v49 | 2020-10-05 | English | Compare |
v48 | 2020-09-28 | French | Compare |
v47 | 2020-09-28 | English | Compare |
v46 | 2020-09-21 | French | Compare |
v45 | 2020-09-21 | English | Compare |
v44 | 2020-08-26 | French | Compare |
v43 | 2020-08-26 | English | Compare |
v42 | 2020-06-29 | French | Compare |
v41 | 2020-06-29 | English | Compare |
v40 | 2020-06-08 | French | Compare |
v39 | 2020-06-08 | English | Compare |
v38 | 2020-05-11 | French | Compare |
v37 | 2020-05-11 | English | Compare |